Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948191632> ?p ?o ?g. }
- W2948191632 endingPage "11070" @default.
- W2948191632 startingPage "11059" @default.
- W2948191632 abstract "MYC is one of the most important oncogenes and is overexpressed in the majority of cancers. G-Quadruplexes are noncanonical four-stranded DNA secondary structures that have emerged as attractive cancer-specific molecular targets for drug development. The G-quadruplex formed in the proximal promoter region of the MYC oncogene (MycG4) has been shown to be a transcriptional silencer that is amenable to small-molecule targeting for MYC suppression. Indenoisoquinolines are human topoisomerase I inhibitors in clinical testing with improved physicochemical and biological properties as compared to the clinically used camptothecin anticancer drugs topotecan and irinotecan. However, some indenoisoquinolines with potent anticancer activity do not exhibit strong topoisomerase I inhibition, suggesting a separate mechanism of action. Here, we report that anticancer indenoisoquinolines strongly bind and stabilize MycG4 and lower MYC expression levels in cancer cells, using various biochemical, biophysical, computer modeling, and cell-based methods. Significantly, a large number of active indenoisoquinolines cause strong MYC downregulation in cancer cells. Structure-activity relationships of MycG4 recognition by indenoisoquinolines are investigated. In addition, the analysis of indenoisoquinoline analogues for their MYC-inhibitory activity, topoisomerase I-inhibitory activity, and anticancer activity reveals a synergistic effect of MYC inhibition and topoisomerase I inhibition on anticancer activity. Therefore, this study uncovers a novel mechanism of action of indenoisoquinolines as a new family of drugs targeting the MYC promoter G-quadruplex for MYC suppression. Furthermore, the study suggests that dual targeting of MYC and topoisomerase I may serve as a novel strategy for anticancer drug development." @default.
- W2948191632 created "2019-06-14" @default.
- W2948191632 creator A5026197050 @default.
- W2948191632 creator A5030947777 @default.
- W2948191632 creator A5048808165 @default.
- W2948191632 creator A5062572383 @default.
- W2948191632 creator A5079123375 @default.
- W2948191632 creator A5086612605 @default.
- W2948191632 date "2019-06-03" @default.
- W2948191632 modified "2023-10-12" @default.
- W2948191632 title "Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the <i>MYC</i> Promoter G-Quadruplex and Downregulate <i>MYC</i>" @default.
- W2948191632 cites W1721320694 @default.
- W2948191632 cites W1965254413 @default.
- W2948191632 cites W1966863156 @default.
- W2948191632 cites W1970890275 @default.
- W2948191632 cites W1974067967 @default.
- W2948191632 cites W1985588649 @default.
- W2948191632 cites W1990502898 @default.
- W2948191632 cites W1990635146 @default.
- W2948191632 cites W1996949194 @default.
- W2948191632 cites W1997812288 @default.
- W2948191632 cites W2000929500 @default.
- W2948191632 cites W2001570602 @default.
- W2948191632 cites W2009423060 @default.
- W2948191632 cites W2021536610 @default.
- W2948191632 cites W2022655175 @default.
- W2948191632 cites W2026290591 @default.
- W2948191632 cites W2027047459 @default.
- W2948191632 cites W2027143034 @default.
- W2948191632 cites W2027423337 @default.
- W2948191632 cites W2035667154 @default.
- W2948191632 cites W2043720815 @default.
- W2948191632 cites W2055332649 @default.
- W2948191632 cites W2056072994 @default.
- W2948191632 cites W2059078891 @default.
- W2948191632 cites W2059306569 @default.
- W2948191632 cites W2060916958 @default.
- W2948191632 cites W2064772366 @default.
- W2948191632 cites W2071187523 @default.
- W2948191632 cites W2079076987 @default.
- W2948191632 cites W2087312216 @default.
- W2948191632 cites W2089937596 @default.
- W2948191632 cites W2090411726 @default.
- W2948191632 cites W2097774235 @default.
- W2948191632 cites W2100013366 @default.
- W2948191632 cites W2124021652 @default.
- W2948191632 cites W2138366746 @default.
- W2948191632 cites W2140590042 @default.
- W2948191632 cites W2143583668 @default.
- W2948191632 cites W2147960762 @default.
- W2948191632 cites W2155773930 @default.
- W2948191632 cites W2161577298 @default.
- W2948191632 cites W2167869412 @default.
- W2948191632 cites W2222589778 @default.
- W2948191632 cites W2258421680 @default.
- W2948191632 cites W2329555214 @default.
- W2948191632 cites W2331778791 @default.
- W2948191632 cites W2332175864 @default.
- W2948191632 cites W2390517379 @default.
- W2948191632 cites W2399820942 @default.
- W2948191632 cites W2411740509 @default.
- W2948191632 cites W2517296131 @default.
- W2948191632 cites W2520749639 @default.
- W2948191632 cites W2523410070 @default.
- W2948191632 cites W2529820863 @default.
- W2948191632 cites W2600657762 @default.
- W2948191632 cites W2602591481 @default.
- W2948191632 cites W2605511634 @default.
- W2948191632 cites W2611414349 @default.
- W2948191632 cites W2692768525 @default.
- W2948191632 cites W2714306317 @default.
- W2948191632 cites W2725627050 @default.
- W2948191632 cites W2751110354 @default.
- W2948191632 cites W2950153068 @default.
- W2948191632 cites W4236973945 @default.
- W2948191632 doi "https://doi.org/10.1021/jacs.9b02679" @default.
- W2948191632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7307421" @default.
- W2948191632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31283877" @default.
- W2948191632 hasPublicationYear "2019" @default.
- W2948191632 type Work @default.
- W2948191632 sameAs 2948191632 @default.
- W2948191632 citedByCount "57" @default.
- W2948191632 countsByYear W29481916322020 @default.
- W2948191632 countsByYear W29481916322021 @default.
- W2948191632 countsByYear W29481916322022 @default.
- W2948191632 countsByYear W29481916322023 @default.
- W2948191632 crossrefType "journal-article" @default.
- W2948191632 hasAuthorship W2948191632A5026197050 @default.
- W2948191632 hasAuthorship W2948191632A5030947777 @default.
- W2948191632 hasAuthorship W2948191632A5048808165 @default.
- W2948191632 hasAuthorship W2948191632A5062572383 @default.
- W2948191632 hasAuthorship W2948191632A5079123375 @default.
- W2948191632 hasAuthorship W2948191632A5086612605 @default.
- W2948191632 hasBestOaLocation W29481916322 @default.
- W2948191632 hasConcept C104317684 @default.
- W2948191632 hasConcept C121608353 @default.
- W2948191632 hasConcept C127561419 @default.
- W2948191632 hasConcept C147897179 @default.